Pharma pricing policy: What changes are likely to be made?

The Cabinet is also likely to approve the Pharma pricing policy, despite drug experts alleging that there are major loopholes in the pricing of drugs. This reform is expected to make pricing more consumer friendly, but perhaps not in the long run.

October 04, 2012 / 16:49 IST

The Cabinet is also likely to approve the Pharma pricing policy, despite drug experts alleging that there are major loopholes in the pricing of drugs. This reform is expected to make pricing more consumer friendly, but perhaps not in the long run.

Here are the key things to watch out for:

Cabinet to consider bringing 348 essential drugs under price control
348 drugs part of the National List of Essential Medicines
Total sales in excess of Rs 25,000 cr per year
Constitute 60% of the total sales
Cabinet to consider using weighted avg prices of drugs
Weighted avg prices for drugs with mkt share of 1%

first published: Oct 4, 2012 04:48 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347